Substance Abuse, Addiction & Deterrence

Mandatory opioid tapers could sometimes do more harm than good, international medical experts warn in an open letter to health authorities.

Articles

A six-component early-discharge rule allows for safe discharge of some patients one hour after naloxone administration for suspected opioid overdose, researchers report.

The rate of benzodiazepine use among US adults has increased to 12.6%, according to a study published online in Psychiatric Services. Misuse now accounts for nearly 20% of overall use.

Mandatory opioid tapers could sometimes do more harm than good, international medical experts warn in an open letter to health authorities.

In abstinence-motivated people with opioid dependence, symptoms of anxiety, depression or insomnia should not prevent switching from an opioid agonist to extended-release naltrexone (XR-NTX), researchers in Norway say.

Buprenorphine can be safely continued during perioperative pain management in patients taking it for opioid use disorder, researchers report.

Pages

Blogs

Personal reports from treatment subjects are as compelling as the quantitative data.

The idea of using these drugs as catalysts for psychotherapeutic change challenges biological psychiatry’s predominant orientation towards mental disease as something that is managed or palliated, but not cured.

For clinicians who have only encountered these substances in the context of patients who are abusing them for their intoxicating qualities, inquiries into the therapeutic potential of these compounds may seem bewildering, even reckless.

Pages

Posters

Ajay Singh, MD; Amanpreet Sandhu, MD; Harinder Kaur, MD
Margaret Duncan, MD, PhD; Feride Frech, MPH, PhD; Mugdha Gore, PhD, Bpharm
Bernd Wollschlaeger, MD, FAAFP, FASAM; Leslie Montejano, MA, CCRP; Tina Willson, PhD; Naoko Ronquest, PhD; Paul Juneau, MS; Vijay Nadipelli, BPharm, MS

Pages

Video

Joseph P. McEvoy, MD, discusses how cannabis affects the risk of schizophrenia and the course of the disease. Dr. McEvoy is Professor of Psychiatry and Health Behavior and the I. Clark Case Chair in Psychotic Disorders at the Medical College of Georgia.

Psych Congress Steering Committee member Andrew Penn, RN, MS, NP, CNS, APRN-BC, discusses strategies that clinicians can use to engage with patients who are using cannabis.

Psych Congress Steering Committee member Andrew Penn, RN, MS, NP, CNS, APRN-BC, discusses the ways in which cannabis use affects development of the brain.

Pages